RCM
RA Capital Management Portfolio holdings
AUM
$5.94B
This Quarter Return
+23.44%
1 Year Return
+18.15%
3 Year Return
+417.5%
5 Year Return
+458.13%
10 Year Return
+21,247.51%
AUM
$756M
AUM Growth
+$756M
(-22%)
Cap. Flow
-$294M
Cap. Flow
% of AUM
-38.88%
Top 10 Holdings %
Top 10 Hldgs %
80.1%
Holding
36
New
5
Increased
2
Reduced
13
Closed
10
Top Buys
| 1 |
ARAV
Aravive, Inc. Common Stock
ARAV
|
$50.1M |
| 2 |
DYAX
DYAX CORPORATION
DYAX
|
$24.4M |
| 3 |
Akebia Therapeutics
AKBA
|
$16.6M |
| 4 |
SCYNEXIS
SCYX
|
$6.74M |
| 5 |
IMMU
Immunomedics Inc
IMMU
|
$3.65M |
Top Sells
| 1 |
Prothena Corp
PRTA
|
$59.6M |
| 2 |
ISEE
IVERIC bio, Inc. Common Stock
ISEE
|
$51.2M |
| 3 |
Sangamo Therapeutics
SGMO
|
$37.1M |
| 4 |
Arrowhead Research
ARWR
|
$33.4M |
| 5 |
PTC Therapeutics
PTCT
|
$25.7M |
Sector Composition
| 1 | Healthcare | 79.1% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
ACHN
1
DELISTED
Achillion Pharmaceuticals, Inc.
ACHN
| $170M | 17.21% | 22,486,007 -880,000 | -4% | -$6.66M |
|
|
DYAX
2
DELISTED
DYAX CORPORATION
DYAX
| $95.8M | 9.69% | 9,982,578 +2,546,108 | +34% | +$24.4M |
|
3
Enanta Pharmaceuticals
ENTA
$180M
| $66.3M | 6.7% | 1,539,586 -1,492 | -0.1% | -$64.3K |
|
|
DRNA
4
DELISTED
Dicerna Pharmaceuticals, Inc.
DRNA
| $54.8M | 5.54% | 2,428,571 | – | – |
|
|
ARAV
5
DELISTED
Aravive, Inc. Common Stock
ARAV
| $50.1M | 5.07% | +1,203,002 | New | +$50.1M |
|
|
6
Sangamo Therapeutics
SGMO
$157M
| $42.6M | 4.31% | 2,791,305 -2,430,748 | -47% | -$37.1M |
|
7
BioCryst Pharmaceuticals
BCRX
$1.74B
| $40.8M | 4.12% | 3,198,529 -1,148,927 | -26% | -$14.6M |
|
|
VIRX
8
DELISTED
Viracta Therapeutics, Inc. Common Stock
VIRX
| $31.7M | 3.21% | 4,869,261 | – | – |
|
9
Novavax
NVAX
$1.21B
| $30.8M | 3.11% | 6,661,731 -3,276,519 | -33% | -$15.1M |
|
10
Dynavax Technologies
DVAX
$1.19B
| $22.5M | 2.27% | 14,036,590 -3,847,364 | -22% | -$6.16M |
|
|
ISEE
11
DELISTED
IVERIC bio, Inc. Common Stock
ISEE
| $22.3M | 2.26% | 527,941 -1,209,915 | -70% | -$51.2M |
|
|
RPRX
12
DELISTED
Repros Therapeutics Inc.
RPRX
| $21.1M | 2.13% | 1,219,381 -219,667 | -15% | -$3.8M |
|
|
BLUE
13
DELISTED
bluebird bio
BLUE
| $19.4M | 1.96% | 503,062 +35,644 | +8% | +$1.37M |
|
14
TherapeuticsMD
TXMD
$12.8M
| $19M | 1.92% | 4,303,066 -5,535,383 | -56% | -$24.5M |
|
|
15
Akebia Therapeutics
AKBA
$833M
| $16.6M | 1.68% | +597,363 | New | +$16.6M |
|
16
Xencor
XNCR
$580M
| $11.8M | 1.19% | 1,016,735 -1,708,265 | -63% | -$19.8M |
|
17
EyePoint Pharmaceuticals
EYPT
$797M
| $11.1M | 1.12% | 2,555,659 | – | – |
|
|
18
Arrowhead Research
ARWR
$3.05B
| $8.65M | 0.87% | 604,346 -2,337,570 | -79% | -$33.4M |
|
|
19
SCYNEXIS
SCYX
$34.9M
| $6.74M | 0.68% | +840,000 | New | +$6.74M |
|
|
ALIM
20
DELISTED
Alimera Sciences, Inc.
ALIM
| $3.99M | 0.4% | 666,667 | – | – |
|
|
OCRX
21
DELISTED
Ocera Therapeutics, Inc.
OCRX
| $3.75M | 0.38% | 490,697 -37,100 | -7% | -$283K |
|
|
IMMU
22
DELISTED
Immunomedics Inc
IMMU
| $3.65M | 0.37% | +1,000,000 | New | +$3.65M |
|
23
Tenax Therapeutics
TENX
$27.3M
| $1.29M | 0.13% | +315,298 | New | +$1.29M |
|
24
Neurocrine Biosciences
NBIX
$13.8B
| $1.02M | 0.1% | 68,968 -1,100,116 | -94% | -$16.3M |
|
25
Acadia Pharmaceuticals
ACAD
$4.38B
| – | – | -250,000 | Closed | -$6.08M |
|